ROYAL BANK OF CANADA - ATHIRA PHARMA INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q3 2023$4,000
+300.0%
1,930
+589.3%
0.00%
Q2 2023$1,000
-80.0%
280
-85.3%
0.00%
Q1 2023$5,000
-70.6%
1,903
-63.8%
0.00%
Q4 2022$17,000
+70.0%
5,257
+48.5%
0.00%
Q3 2022$10,000
+400.0%
3,540
+621.0%
0.00%
Q2 2022$2,000
-98.6%
491
-95.4%
0.00%
Q1 2022$143,000
-56.9%
10,617
-58.3%
0.00%
Q4 2021$332,000
-65.1%
25,462
-74.9%
0.00%
Q3 2021$952,000
-39.9%
101,513
-34.4%
0.00%
Q2 2021$1,585,000
-34.7%
154,739
+17.2%
0.00%
-100.0%
Q1 2021$2,429,000
-8.8%
131,995
+69.8%
0.00%0.0%
Q4 2020$2,663,000
+424.2%
77,747
+182.7%
0.00%
Q3 2020$508,00027,5000.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
AWH Capital, L.P. 230,000$351,3510.48%
Perceptive Advisors 4,797,278$14,632,0000.46%
Ikarian Capital, LLC 784,200$2,393,0000.44%
Bristlecone Advisors, LLC 700,926$2,138,0000.26%
Altium Capital Management LP 200,100$610,0000.24%
RA Capital Management 1,878,000$5,728,0000.15%
Logos Global Management LP 220,000$671,0000.12%
PATHSTONE FAMILY OFFICE, LLC 1,688,840$5,150,9630.11%
Ikarian Capital, LLC 199,500$609,0000.11%
SG3 Management, LLC 206,000$628,0000.07%
View complete list of ATHIRA PHARMA INC shareholders